Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8592397 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(11 months from now) | |
US9457036 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(11 months from now) | |
US9744181 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(11 months from now) | |
US8716264 | GILEAD | Compositions and methods for combination antiviral therapy |
Jan, 2024
(11 months from now) |
Market Authorisation Date: 02 August, 2004
Treatment: Treatment of hiv; Method of treatment of adults infected with hiv-1; Treatment of hiv-1 infection in pediatric patients 12 years of age and older; Treatment of hiv infection
Dosage: TABLET;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic